Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411569200 on November 16, 2004

J. Biol. Chem., Vol. 280, Issue 6, 4037-4047, February 11, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/6/4037    most recent
M411569200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, B. J.
Right arrow Articles by Suhrbier, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, B. J.
Right arrow Articles by Suhrbier, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Heat Shock Protein 10 Inhibits Lipopolysaccharide-induced Inflammatory Mediator Production*

Barbara J. Johnson{ddagger}§, Thuy T. T. Le¶, Caroline A. Dobbin{ddagger}, Tatjana Banovic¶, Christopher B. Howard{ddagger}, Flor de Maria Leon Flores{ddagger}, Daina Vanags{ddagger}, Dean J. Naylor{ddagger}, Geoffrey R. Hill¶, and Andreas Suhrbier¶

From the {ddagger}CBio Limited, 17 Wakefield St., Alderley, Queensland 4051, Australia and the Queensland Institute of Medical Research (Australian National Centre for International and Tropical Health and Nutrition and Department of Pathology, University of Queensland), 300 Herston Rd., Herston, Queensland 4029, Australia

Heat shock protein 10 (Hsp10) and heat shock protein 60 (Hsp60) were originally described as essential mitochondrial proteins involved in protein folding. However, both proteins have also been shown to have a number of extracellular immunomodulatory activities. Here we show that purified recombinant human Hsp10 incubated with cells in vitro reduced lipopolysaccharide (LPS)-induced nuclear factor-{kappa}B activation and secretion of several inflammatory mediators from RAW264.7 cells, murine macrophages, and human peripheral blood mononuclear cells. Induction of tolerance by contaminating LPS was formally excluded as being responsible for Hsp10 activity. Treatment of mice with Hsp10 before endotoxin challenge resulted in the reduction of serum tumor necrosis factor-{alpha} and RANTES (regulated upon activation, normal T cell expressed and secreted) levels and an elevation of serum interleukin-10 levels. Hsp10 treatment also delayed mortality in a murine graft-versus-host disease model, where gut-derived LPS contributes to pathology. We were unable to confirm previous reports that Hsp10 has tumor growth factor properties and suggest that Hsp10 exerts anti-inflammatory activity by inhibiting Toll-like receptor signaling possibly by interacting with extracellular Hsp60.


Received for publication, October 12, 2004

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondences should be addressed. Tel.: 61-7-3252-1022; Fax: 61-7-3252-1305; E-mail: barbara.johnson{at}cbio.com.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
S. Broadley, D Vanags, B Williams, B Johnson, D Feeney, L Griffiths, S Shakib, G Brown, A Coulthard, P Mullins, et al.
Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis
Multiple Sclerosis, March 1, 2009; 15(3): 329 - 336.
[Abstract] [PDF]


Home page
Arch DermatolHome page
B. Williams, D. Vanags, S. Hall, C. McCormack, P. Foley, J. Weiss, B. Johnson, E. Latz, and D. Feeney
Efficacy and Safety of Chaperonin 10 in Patients With Moderate to Severe Plaque Psoriasis: Evidence of Utility Beyond a Single Indication
Arch Dermatol, May 1, 2008; 144(5): 683 - 685.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. Darnell, W. A. Schroder, J. Gardner, D. Harrich, H. Yu, R. L. Medcalf, D. Warrilow, T. M. Antalis, S. Sonza, and A. Suhrbier
SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication
J. Biol. Chem., October 20, 2006; 281(42): 31348 - 31358.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Ruby, C. Whittaker, D. R. Withers, M. K. Chelbi-Alix, V. Morin, A. Oudin, J. R. Young, and R. Zoorob
Transcriptional profiling reveals a possible role for the timing of the inflammatory response in determining susceptibility to a viral infection.
J. Virol., September 1, 2006; 80(18): 9207 - 9216.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Henderson, E. Allan, and A. R. M. Coates
Stress Wars: the Direct Role of Host and Bacterial Molecular Chaperones in Bacterial Infection
Infect. Immun., July 1, 2006; 74(7): 3693 - 3706.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement